Myomo, Inc. (MYO)
NYSEAMERICAN: MYO · IEX Real-Time Price · USD
3.530
+0.260 (7.95%)
May 1, 2024, 4:00 PM EDT - Market closed

Myomo Revenue

In the year 2023, Myomo had annual revenue of $19.24M with 23.70% growth. Revenue in the quarter ending December 31, 2023 was $4.76M with 17.69% year-over-year growth.

Revenue (ttm)
$19.24M
Revenue Growth
+23.70%
P/S Ratio
5.23
Revenue / Employee
$190,507
Employees
101
Market Cap
100.56M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202319.24M3.69M23.70%
Dec 31, 202215.56M1.70M12.26%
Dec 31, 202113.86M6.27M82.72%
Dec 31, 20207.58M3.75M97.60%
Dec 31, 20193.84M1.39M57.02%
Dec 31, 20182.44M885.24K56.79%
Dec 31, 20171.56M455.59K41.29%
Dec 31, 20161.10M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
PetMed Express 276.97M
OptiNose 70.99M
Allurion Technologies 53.47M
Elutia 24.75M
HOOKIPA Pharma 20.13M
BioXcel Therapeutics 1.38M
Genelux 170.00K
Revenue Rankings